摘要
腺性膀胱炎(cystitis glandular,CG)属于膀胱黏膜化生性病变,自1899年由Stoerk首次报道,至今已有100多年的历史,其是否应被视为癌前病变一直存有争议。CG临床表现复杂多样,且缺乏疾病特异性症状。目前国际上无论欧洲还是北美,尚没有关于CG的诊治指南和共识。中华医学会泌尿外科学分会腺性膀胱炎诊治专家共识编写组,于2020年8月在《中华泌尿外科杂志》发表的《腺性膀胱炎的临床诊断和治疗的专家共识》对CG的发病机制、临床分型、诊断标准统一了认识,对CG的治疗策略做了规范化指导。本文就此版专家共识中一些与临床诊疗密切相关的内容进行解读。
Cystitis glandularis(CG)is a metaplastic lesion of the bladder mucosa,as first reported by Stoerk in 1899.Whether CG should be considered a precancerous lesion has been a matter of controversy for more than 100 years.Its clinical manifestations are complex and diverse,and disease-specific symptoms are absent.No guidelines or consensus opinions have been formulated regarding the diagnosis and treatment of CG in Europe or North America.’The Expert Consensus on the Diagnosis and Treatment of Cystitis Glandularis’was published in the’Chinese Journal of Urology’in August 2020 by the Expert Consensus Group of the Chinese Urological Association.This edition of the consensus unifies understanding of the pathogenesis,clinical classification,and diagnostic criteria for CG,and provides standardized guidelines for CG treatment strategies.This article discusses some of the content relating to clinical diagnosis and treatment in this edition of the expert consensus.
作者
张保
Zhang Bao(Department of Urology,Aerospace Center Hospital,Beijing,100000,China)
出处
《泌尿外科杂志（电子版）》
2021年第4期28-31,共4页
Journal of Urology for Clinicians(Electronic Version)
关键词
腺性膀胱炎
诊断
治疗
共识
解读
Cystitis glandularis
Diagnosis
Treatment
Consensus
作者简介
通讯作者:张保,E-mial:baoztj@sina.com
